Early placebo-controlled rintatolimod trial
Strayer DR et al. · 1994 · Clinical Infectious Diseases
Indexed 2026-11-12.
Reported findings and study design
Reported findings
Randomized multicenter double-blind comparison of IV poly(I)·poly(C12U) and placebo over 24 weeks.
Dose, route and schedule
Randomized multicenter double-blind comparison of IV poly(I)·poly(C12U) and placebo over 24 weeks.
Protocol source ↗ · Original article abstract
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Functional measures | The paper reports differences favoring active treatment for Karnofsky performance (p<0.03), treadmill duration (p=0.01) and activities of daily living (p<0.04). |
The historical CDC definition and secondary measures limit comparisons with current studies.
Source for these results ↗ · Reviewed 2026-11-12
For research and education. Consult a qualified clinician for medical advice.
Study limitations and source details
Study limitations
- The historical CDC definition and secondary measures limit comparisons with current studies.
Source access
Randomized multicenter double-blind comparison of IV poly(I)·poly(C12U) and placebo over 24 weeks.
Source reviewed 2026-11-12.
Citation and original source
Original source: Strayer DR et al.. Early placebo-controlled rintatolimod trial Clinical Infectious Diseases 1994.
Molekul research summary: https://molekul.io/research/rintatolimod-amp-1994. Cite the original publication for its findings and this page when referring to Molekul’s summary or evidence appraisal.
Bibliography entry